Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
78.80    -1.00 (-1.25%)
Bid:
77.80
Ask:
78.30
Spread: 0.50 (0.643%)
Market Cap: £129.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Q1 Trading update

26 Apr 2018 07:00

RNS Number : 1543M
Synthomer PLC
26 April 2018
 

April 26th 2018

Synthomer plc

Q1 Trading update

Solid Q1 performance in line with expectations; 2018 outlook unchanged

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the first quarter ended March 31st, 2018.

Trading

Europe and North America

The Europe and North America segment delivered another solid performance. Volumes were higher than the comparative period predominantly reflecting the positive impact of the Speciality Additives and Pischelsdorf SBR latex acquisitions. Unit margins were marginally lower mainly due to the transactional impact of European sales denominated in US dollars.

Asia and Rest of World

The Asia and Rest of World segment remained stable with performance in line with our expectations. Nitrile latex volumes were marginally higher than a weaker comparative period when customer spending was impacted by the volatile raw material environment. Unit margins were broadly in line with Q1 2017. We remain cautiously optimistic on the continued Nitrile latex demand growth and margin development recognising that our 90kt capacity is on track to come on line in late Q3 2018.

Financial Position

Net debt increased from £180m at the year end to £246m at 31 March 2018. This reflected completion of the acquisition of the BASF Austrian SBR business and assets in Pischelsdorf for €29m (£25m) in January and seasonal working capital movements which was, as we saw in 2017, impacted by a rising raw material price environment.

2018 outlook unchanged

Overall, the Group continues to trade in line with the Board's expectations, and accordingly the view for Full Year 2018 remains unchanged.

-ENDS-

 

ENQUIRIES:

Calum MacLean, Chief Executive Officer

Charles Armitstead

Stephen Bennett, Chief Financial Officer

Teneo

Tel: + 44 1279 436211

Tel: + 44 20 3603 5220

 

The Company will hold a conference call for investors and analysts at 0800 BST today. 

Please dial 0800 3589473 PIN: 92017967# to gain access to the call.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKPDKCBKDCQB
Date   Source Headline
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration
11th Nov 20212:24 pmRNSDirector/PDMR Shareholding
4th Nov 20212:11 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSNew Chief Executive
28th Oct 20213:17 pmRNSResult of Placing
28th Oct 20217:00 amRNSAcquisition
28th Oct 20217:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
30th Sep 20213:08 pmRNSDirectorate Change
10th Sep 20218:23 amRNSDirector Declaration
5th Aug 20217:01 amRNSBoard Update
5th Aug 20217:00 amRNSInterim Results
20th Jul 202112:05 pmRNSSynthomer plc receives Green Economy Mark
19th Jul 20217:00 amRNSTrading Update
14th Jul 202111:02 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSAppointment of Non-Executive Director
6th Jul 202112:37 pmRNSDirector/PDMR Shareholding
25th Jun 202110:01 amRNSFurther re Appointment of Group CEO
23rd Jun 20217:00 amRNSAppointment of Group Chief Executive Officer
18th May 20213:53 pmRNSDirector Declaration
12th May 20212:56 pmRNSDirector Declaration
6th May 20214:17 pmRNSDirector Declaration
6th May 20213:15 pmRNSDirector/PDMR Shareholding
29th Apr 20214:01 pmRNSResult of AGM
21st Apr 20217:00 amRNSQ1 Trading Update
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:56 amRNSAnnual Financial Report
19th Mar 20212:38 pmRNSDirector/PDMR Shareholding
12th Mar 20213:17 pmRNSDirector/PDMR Shareholding
12th Mar 20213:16 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
11th Mar 20219:43 amRNSHolding(s) in Company
4th Mar 202112:43 pmRNSPreliminary results – correction
4th Mar 20217:00 amRNSPreliminary Results year ended 31 December 2020
1st Mar 202112:58 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSStatement RE: Press Speculation
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:38 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSPre-Close Trading Update and Board Update
12th Jan 20219:36 amRNSHolding(s) in Company
6th Jan 20219:10 amRNSDirector Declaration
4th Jan 202110:09 amRNSDirector Declaration
23rd Dec 20204:54 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSAppointment of New Chair
18th Nov 20207:00 amRNSInvestor Seminar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.